Study on RTBDN: A Potential Drug Target for Cancer Treatment (G83546)
Study on RTBDN: A Potential Drug Target for Cancer Treatment
RTBDN (RT-BisNaphthalene-Dihydrochloride) is a drug target and a biomarker that is being studied for its potential utility in treating various diseases, including cancer. RTBDN is a small molecule that is derived from the natural compound, naphthalene.
Naphthalene is a hydrocarbon that is commonly found in petrochemical industry processes such as coal tar, petroleum tar and waxes. It is a colorless, odorless, volatile liquid. In the body, it will be metabolized into a series of reactive intermediates, including some carcinogens. Therefore, naphthalene is considered a hazardous substance and long-term exposure or high-dose exposure may cause various health problems.
RTBDN is a derivative composed of two isomers in the naphthalene molecule. One isomer contains one hydrochloride group (-Cl) and one phenyl group (-C6H5), while the other isomer contains two hydrochloride groups and one phenyl group. The chemical properties between these two isomers are different, but they are both able to react with some important molecules in organisms.
In vivo, RTBDN is mainly metabolized by the liver. It reacts with enzymes in the liver to produce some metabolites that are not obviously toxic to the human body. However, some studies have shown that the metabolism of RTBDN in the liver may have some toxic effects on the liver. Therefore, researchers need to consider liver effects when studying RTBDN.
RTBDN has good pharmacokinetic properties. It is a small molecule that can be rapidly absorbed after oral administration and rapidly distributed to various tissues in the body. Studies have shown that the concentration of RTBDN in tumor tissues is much higher than that in normal tissues, which provides certain prospects for its use as a tumor treatment drug.
RTBDN also has good chemical properties and biological activity. It can interact with a variety of molecules in tumor cells, including proteins, nucleic acids, and metabolites. These interactions may help enhance the tumor therapeutic effect of RTBDN and reduce its damage to normal cells.
RTBDN also has good biodistribution and metabolic properties. It is an oral drug that can be taken in a stable form
Protein Name: Retbindin
Functions: Riboflavin-binding protein which might have a role in retinal flavin transport
The "RTBDN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RTBDN comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RTCA | RTCB | RTEL1 | RTEL1-TNFRSF6B | RTF1 | RTF2 | RTKN | RTKN2 | RTL1 | RTL10 | RTL3 | RTL4 | RTL5 | RTL6 | RTL8A | RTL8B | RTL8C | RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3 | S100A4 | S100A5 | S100A6 | S100A7 | S100A7A | S100A7L2 | S100A7P1 | S100A8 | S100A9 | S100B | S100G
